Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Hydrops Fetalis

Synonyms: hydrops, fetal hydrops, foetal hydrops, universal oedema of the newborn.

First described by Ballantyne in 1892, this is a serious condition defined as abnormal fluid accumulation in 2 or more fetal compartments. These may include ascites, pleural effusion, pericardial effusion, and skin oedema. It may also be associated with polyhydramnios and placental oedema.
Until fairly recently this condition was believed to be due to Rhesus (Rh) blood group isoimmunization of the fetus. Recognition of factors other than isoimmune haemolytic disease has brought about the term nonimmune hydrops to identify those cases in which the fetal disorder was caused by factors other than isoimmunization. The introduction of rhesus immunoglobulin (Ig) prophylaxis in at-risk mothers, also showed that the nonimmune causes of hydrops were, in fact, more common than had been suspected.

Epidemiology

It occurs in between 1 in 600 and 1 in 4,000 pregnancies.1
This varies according to the population risk of the conditions listed below e.g. in Thailand the expected frequency of hydrops, from homozygous alpha-thalassemia or Bart hydrops is 1 in 500 to 1 in 1,500 pregnancies.2

Aetiology

Haematological causes

  • Isoimmunization (haemolytic disease of the newborn; erythroblastosis fetalis); Rhesus, but also Kell, ABO and Duffy.
  • Other haemolytic disorders e.g. GP6D, Glucose phosphate isomerase deficiency, Pyruvate kinase deficiency
  • Disorders of red cell production e.g. Congenital dyserythropoietic anaemia, Diamond-Blackfan syndrome, Lethal hereditary spherocytosis, Congenital erythropoietic porphyria (G?nther disease), Alpha-thalassemia (Bart hemoglobinopathy)
  • Fetal haemorrhage e.g. Intracranial or intraventricular, hepatic laceration or subcapsular, fetomaternal haemorrhage or twin-to-twin transfusion.

Cardiac Causes

  • Abnormalities of left ventricular outflow e.g. Aortic valvular stenosis or atresia, Coarctation of the aorta, Truncus arteriosus, Hypoplastic left heart, Endocardial fibroelastosis
  • Abnormalities of right ventricular outflow e.g. Pulmonary valvular atresia or insufficiency, Ebstein anomaly, Arteriovenous malformations, haemangiomas.
  • No structural anomalies e.g. Superior vena cava or Inferior vena cava occlusion, Intrathoracic or abdominal masses, disorders of lymphatic drainage, arrhythmias; supraventricular tachycardia or congenital heart block - 66-75% occur in pregnancies complicated by maternal collagen disease; prenatal closure of the foramen ovale or ductus arteriosus, myocarditis, or idiopathic arterial calcification or hypercalcaemia.

Infective causes

Metabolic and other causes

Tumours

Especially sacrococcygeal teratoma

Management

This depends on an accurate diagnosis of the cause of the hydrops. Interventions are sometimes possible, and helping the parents decide whether to continue the pregnancy or opt for a termination depends upon the whether the abnormalities are compatible with the continued survival of the fetus and problems likely after birth.

  • Parental involvement and guidance are fundamental requirements and require full knowledge by the parents of all possible potential consequences.
  • If the decision is made to continue the pregnancy, the next step is to decide whether to intervene with invasive fetal treatment.
  • Consideration should also be given to the point at which preterm delivery represents less risk for the fetus than continuing the pregnancy.
  • Decisions about fetal treatment are inevitably uncertain, because a concrete evidence base is not available.
  • Intrauterine intraperitoneal fetal transfusion with packed RBCs has been successfully used to treat severely anaemic fetuses of the isoimmunized pregnancy.
  • Treatment for fetal arrhythmias has included doing nothing, administering drugs, and immediate delivery, if maturity permits.
  • Fetal pacing has been reported. Various drugs have also been used. Adenosine is effective with supraventricular arrhythmias,4 and corticosteroid therapy is effective for complete fetal heart block associated with maternal collagen diseases.5
Prognosis

This depends on the underlying cause.
Spontaneous remission has been reported in hundreds of cases. Underlying causes in these cases include cardiac arrhythmias, twin-to-twin transfusion syndrome, cystic hygroma with or without Noonan syndrome, both Parvovirus and CMV infections and idiopathic ascites or pleural effusions.


Document References
  1. Cassady G. Hydrops Fetalis. e-Medicine; 22nd June, 2006
  2. O-Prasertsawat P, Suthutvoravut S, Chaturachinda K; Hydrops fetalis due to Bart hemoglobinopathy at Ramathibodi Hospital (1978-1987): a 10-year review. J Med Assoc Thai. 1990 Feb;73 Suppl 1:65-8. [abstract]
  3. Dieck D, Schild RL, Hansmann M, et al; Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn. 1999 Dec;19(12):1119-23. [abstract]
  4. Dangel JH, Roszkowski T, Bieganowska K, et al; Adenosine triphosphate for cardioversion of supraventricular tachycardia in two hydropic fetuses. Fetal Diagn Ther. 2000 Nov-Dec;15(6):326-30. [abstract]
  5. Saleeb S, Copel J, Friedman D, et al; Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum. 1999 Nov;42(11):2335-45. [abstract]
Acknowledgements EMIS is grateful to Dr Hayley Willacy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 2281
Document Version: 20
DocRef: bgp24818
Last Updated: 3 Apr 2007
Review Date: 2 Apr 2009




















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page